Genflow Biosciences plc (GENF.L)
| Previous Close | 3.1000 |
| Open | 3.0899 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 2.9725 - 3.2000 |
| 52 Week Range | 1.3230 - 3.4060 |
| Volume | |
| Avg. Volume | 1,406,140 |
| Market Cap | 10.841M |
| Beta (5Y Monthly) | 2.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREGenflow Biosciences PLC Announces Receipt of Grant Funding
Receipt of Grant Funding LONDON, UK / ACCESSWIRE / June 12, 2024 / THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT ...
- ACCESSWIRE
Genflow Biosciences PLC Announces Notice of AGM
Genflow Biosciences Plc Notice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused ...
- ACCESSWIRE
Genflow Biosciences PLC Announces Holding(s) in Company
LONDON, UK / ACCESSWIRE / May 10, 2024 / TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of ...
